Video

Dr. Shapiro on the Surgical Management of Advanced-Stage Melanoma

Richard L. Shapiro, MD, discusses the surgical management of advanced-stage melanoma.

Richard L. Shapiro, MD, associate professor, Department of Surgery, NYU Langone Health’s Perlmutter Cancer Center, discusses the surgical management of advanced-stage melanoma.

Most surgeons say that surgical resectability is a state of mind and that, “almost anything is resectable,” says Shapiro. One question that arises when managing advanced-stage melanoma is how to best serve the patient. Over the years, surgeons have become more cosmetically sensitive to the needs of the patient in terms of surgical resectability. Radical resections have a very small role in the management of melanoma in the modern era, Shapiro adds.

When surgery is likely going to be challenging and/or disfiguring, surgeons now have effective agents that may work in the neoadjuvant setting, such as immunotherapy. Today, patients have more treatment options than they previously had available. Surgeons have to be aware of these newer options in order for the patient to get the best result, concludes Shapiro.

Related Videos
Jennifer Scalici, MD
Steven H. Lin, MD, PhD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Hematology/Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Victor Moreno, MD, PhD
Tiago Biachi, MD, PhD
Dr Girard on De Novo and Acquired Resistance Alterations in HER2-Altered NSCLC
Elias Jabbour, MD
Daniel DeAngelo, MD, PhD
Douglas W. Sborov, MD, MS